ANO1 and colorectal carcinoma: More importantly, the abnormal expression TMEM16A was significantly linked with poor overall survival of patients with GC (Liu et al., 2015), esophageal cancer (Shang et al., 2016), and CRC (Mokutani et al., 2016).